Webb, David R.
University of Leicester · University Hospitals of Leicester NHS Trust
17 papers on CoChatORCID 0000-0002-3932-3339
Most cited papers
- Verified
Type 2 diabetes
Ahmad, E., Lim, S., Lamptey, R., Webb, D. R., & Davies, M. J. (2022) · The Lancet
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 1,120
- Verified
Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis
Morris, D. H., Khunti, K., Achana, F., Srinivasan, B., Gray, L. J., Davies, M. J., & Webb, D. (2013) · Diabetologia
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 229
- Verified
Self-Reported Sitting Time and Markers of Inflammation, Insulin Resistance, and Adiposity
Yates, T., Khunti, K., Wilmot, E. G., Brady, E., Webb, D., Srinivasan, B., Henson, J., Talbot, D., & Davies, M. J. (2012) · American Journal of Preventive Medicine
Physical Activity and HealthAdipokines, Inflammation, and Metabolic Diseases
Cited by 147
- Verified
Defining Obesity Cut-Off Points for Migrant South Asians
Gray, L. J., Yates, T., Davies, M. J., Brady, E., Webb, D. R., Sattar, N., & Khunti, K. (2011) · PLoS ONE
Diabetes, Cardiovascular Risks, and LipoproteinsObesity, Physical Activity, Diet
Cited by 120
- Verified
Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population
Burton, J. O., Gray, L. J., Webb, D. R., Davies, M. J., Khunti, K., Crasto, W., Carr, S. J., & Brunskill, N. J. (2012) · Nephrology Dialysis Transplantation
Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 77
- Verified
Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes
Yates, T., Davies, M. J., Gray, L. J., Webb, D., Henson, J., Gill, J. M. R., Sattar, N., & Khunti, K. (2010) · Preventive Medicine
Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 70
- Verified
The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men
Sargeant, J. A., Aithal, G. P., Takamura, T., Misu, H., Takayama, H., Douglas, J. A., Turner, M. C., Stensel, D. J., Nimmo, M. A., Webb, D. R., et al. (2018) · Applied Physiology, Nutrition, and Metabolism
Adipokines, Inflammation, and Metabolic DiseasesFibroblast Growth Factor Research
Cited by 56
- Verified
Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial
Griffin, S. J., Rutten, G. E. H. M., Khunti, K., Witte, D. R., Lauritzen, T., Sharp, S. J., Dalsgaard, E.-M., Davies, M. J., Irving, G. J., Vos, R. C., et al. (2019) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementHealth Promotion and Cardiovascular Prevention
Cited by 55
- Verified
Type 2 diabetes and impaired physical function: a growing problem
Ahmad, E., Sargeant, J. A., Yates, T., Webb, D. R., & Davies, M. J. (2022) · Diabetology
Diabetes Treatment and ManagementFrailty in Older Adults
Cited by 52
- Verified
Impact of weight loss and weight gain trajectories on body composition in a population at high risk of type 2 diabetes: A prospective cohort analysis
Yates, T., Biddle, G. J. H., Henson, J., Edwardson, C. L., Arsenyadis, F., Goff, L. M., Papamargaritis, D., Webb, D. R., Khunti, K., & Davies, M. J. (2024) · Diabetes, Obesity and Metabolism
Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 31
- Verified
Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial
Ahmad, E., Waller, H. L., Sargeant, J. A., Webb, M. A., Htike, Z. Z., McCann, G. P., Gulsin, G., Khunti, K., Yates, T., Henson, J., et al. (2021) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 27
- Verified
Efficacy of low- and very-low-energy diets in people with type 2 diabetes mellitus: A systematic review and meta-analysis of interventional studies
Kloecker, D. E., Zaccardi, F., Baldry, E., Davies, M. J., Khunti, K., & Webb, D. R. (2019) · Diabetes, Obesity and Metabolism
Dietary Effects on HealthDiet and metabolism studies
Cited by 25
- Verified
The effects of weight‐lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta‐analysis of randomized controlled trials
Jobanputra, R., Sargeant, J. A., Almaqhawi, A., Ahmad, E., Arsenyadis, F., Webb, D. R., Herring, L. Y., Khunti, K., Davies, M. J., & Yates, T. (2023) · Obesity Reviews
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 22
- Verified
Clinical characteristics of people experiencing biochemical hypoglycaemia during an oral glucose tolerance test: Cross-sectional analyses from a UK multi-ethnic population
Parekh, S., Bodicoat, D. H., Brady, E., Webb, D., Mani, H., Mostafa, S., Levy, M. J., Khunti, K., & Davies, M. J. (2014) · Diabetes Research and Clinical Practice
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 16
- Verified
Risk factors and outcome differences in hypoglycaemia‐related hospital admissions: Acase‐control study in England
Zaccardi, F., Webb, D. R., Davies, M. J., Dhalwani, N. N., Housley, G., Shaw, D., Hatton, J. W., & Khunti, K. (2017) · Diabetes, Obesity and Metabolism
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 15
- Verified
Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise training
Willis, S. A., Malaikah, S., Bawden, S. J., Sherry, A. P., Sargeant, J. A., Coull, N. A., Bradley, C. R., Rowlands, A., Naim, I., Ennequin, G., et al. (2024) · Diabetes, Obesity and Metabolism
Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 9
- Verified
Initiation of New Glucose-Lowering Therapies May Act to Reduce Physical Activity Levels: Pooled Analysis From Three Randomized Trials
Yates, T., Sargeant, J. A., King, J. A., Henson, J., Edwardson, C. L., Redman, E., Gulsin, G. S., Brady, E. M., Ahmad, E., Stensel, D. J., et al. (2022) · Diabetes Care
Diabetes Treatment and ManagementPhysical Activity and Health
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free